Stocktoria
Raia Drogasil S.A. RADL3.SA
BR · B3 (Brasil Bolsa) · XBSP · stock · Healthcare · website
Raia Drogasil S.A. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | R$44.3B | R$38.9B | R$34.0B | R$29.1B |
| Gross profit | R$13.0B | R$11.6B | R$10.2B | R$8.8B |
| SG&A expense | R$10.3B | R$9.2B | R$8.2B | R$7.1B |
| Operating income | R$2.6B | R$2.4B | R$2.0B | R$1.9B |
| Interest expense | R$1.1B | R$812.7M | R$737.8M | R$559.2M |
| Income tax | R$147.8M | R$207.6M | R$129.6M | R$178.2M |
| Net income | R$1.3B | R$1.2B | R$1.1B | R$996.1M |
| EPS (diluted) | R$0.78 | R$0.71 | R$0.63 | R$0.59 |
| Operating cash flow | R$1.5B | R$1.9B | R$962.5M | R$839.3M |
| Free cash flow | R$106.5M | R$628.9M | -R$342.0M | -R$349.4M |
| Cash & equivalents | R$509.6M | R$528.0M | R$412.3M | R$433.5M |
| Inventory | R$9.6B | R$8.4B | R$7.2B | R$6.1B |
| Goodwill | R$1.0B | R$1.1B | R$1.1B | R$1.1B |
| Total assets | R$25.2B | R$22.2B | R$20.1B | R$17.2B |
| Total debt | R$8.8B | R$7.7B | R$7.1B | R$6.1B |
| Total liabilities | R$17.8B | R$15.7B | R$14.1B | R$11.8B |
| Shareholders' equity | R$7.3B | R$6.4B | R$6.0B | R$5.3B |
| Share buybacks | R$0 | R$73.3M | R$0 | R$0 |
Growth · year-over-year · Revenue CAGR 15%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +13.8% | +14.4% | +16.9% | — |
| Net income growth | +8.1% | +13.7% | +5.9% | — |
| EPS growth | +10.0% | +12.0% | +7.4% | — |
| Free cash flow growth | -83.1% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · BR · as of 2025-12-31. Figures in BRL. Facts plus Stocktoria's own computed scores — not investment advice.